NOSEBLEEDS

Clinical trials for NOSEBLEEDS explained in plain language.

Never miss a new study

Get alerted when new NOSEBLEEDS trials appear

Sign up with your email to follow new studies for NOSEBLEEDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can a transplant drug stop HHT nosebleeds? small study tests sirolimus

Disease control Completed

This small pilot study tested the safety and effectiveness of the oral drug sirolimus for reducing nosebleeds in people with hereditary hemorrhagic telangiectasia (HHT). Ten adults with moderate to severe nosebleeds took 2 mg of sirolimus daily for 3 months. Researchers tracked b…

Matched conditions: NOSEBLEEDS

Phase: PHASE2 • Sponsor: Unity Health Toronto • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC

NOSEBLEEDS

Get alerted when new NOSEBLEEDS trials appear

Can a transplant drug stop HHT nosebleeds? small study tests sirolimus